QULL
Price
$64.01
Change
-$0.17 (-0.26%)
Updated
Jun 9 closing price
Net Assets
40.87M
Intraday BUY SELL Signals
URTY
Price
$72.70
Change
-$2.35 (-3.13%)
Updated
Jun 10 closing price
Net Assets
334.75M
Intraday BUY SELL Signals
Interact to see
Advertisement

QULL vs URTY

Header iconQULL vs URTY Comparison
Open Charts QULL vs URTYBanner chart's image
QULL vs URTY Comparison Chart in %
View a ticker or compare two or three

Which ETF would AI Choose? ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) vs. ProShares UltraPro Russell2000 (URTY)

Key Takeaways

  • QULL is an exchange-traded note (ETN) offering 2x leveraged exposure to a sector-neutral quality factor index focusing on large- and mid-cap U.S. stocks with high return-on-equity (ROE), low debt, and stable earnings.
  • URTY is an exchange-traded fund (ETF) providing 3x daily leveraged exposure to the Russell 2000 Index, targeting approximately 2,000 small-cap U.S. stocks across diverse sectors.
  • Both products carry identical 0.95% expense ratios but differ structurally: QULL compounds leverage quarterly with a 2051 maturity, while URTY resets daily via derivatives, amplifying volatility.
  • QULL emphasizes quality characteristics within sectors for relative stability; URTY captures broad small-cap beta (market exposure), prone to higher cyclical swings.
  • Recent market rotations favor small caps amid stabilizing rates, but quality factors like QULL offer lower risk profiles in volatile environments.
  • Suitability varies: QULL for quality-tilted leveraged plays, URTY for aggressive short-term small-cap bets.

Introduction

In the current market environment of potential rate stabilization and sector rotations, comparing QULL and URTY highlights contrasting leveraged strategies. QULL targets quality large- and mid-cap stocks through sector-neutral selection, appealing to investors seeking resilient exposure amid economic uncertainty. URTY amplifies small-cap performance, positioning for domestic growth cycles where smaller firms benefit from lower rates and fiscal stimulus. While not direct competitors, both serve tactical traders navigating the shift from mega-cap dominance to broader market participation, offering amplified returns but elevated risks in volatile conditions.

ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) Overview

The ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL), issued by UBS, is an ETN structured as senior unsecured debt maturing February 9, 2051. It seeks 2x leveraged exposure to the compounded quarterly performance of the MSCI USA Sector Neutral Quality GR USD Index, net of fees. This passive, leveraged strategy selects large- and mid-cap U.S. equities from the MSCI USA Index exhibiting superior quality—high ROE (return on equity), low leverage, and earnings stability—relative to sector peers, ensuring sector neutrality.

As an ETN, QULL has no traditional holdings; returns mirror the index (approximately 121 constituents, e.g., top like NVDA, AAPL, MSFT). Sector weights align with the broad market (e.g., Information Technology ~35%, Financials ~12%). The annual tracking fee is 0.95%, plus financing costs tied to SOFR (Secured Overnight Financing Rate). Rebalancing follows the index quarterly. Liquidity reflects NYSE Arca trading, though smaller assets (~$6M) imply wider spreads versus larger peers.

ProShares UltraPro Russell2000 (URTY) Overview

ProShares UltraPro Russell2000 (URTY), managed by ProShare Advisors, is a passive ETF delivering 3x the daily performance of the Russell 2000 Index before fees. Launched in 2010, it targets the small-cap segment (~2,000 stocks, ranked 1,001-3,000 by market cap in the Russell 3000), using derivatives like swaps and futures for leverage, with daily resets.

Holdings (~1,940) mirror the index via financial instruments; top exposures include BE (Bloom Energy, ~1%), CDE (Coeur Mining), Fabrinet. Sector allocations: Industrials ~18%, Healthcare ~16%, Financials ~16%, Technology ~15%, Consumer Discretionary ~13%. Expense ratio: 0.95% (net). Non-diversified structure amplifies volatility; quarterly distributions possible. High liquidity on NYSE Arca (~$350M AUM, tight 0.05% bid-ask spreads) suits active trading.

Industry and Thematic Backdrop

Both ETFs operate amid U.S. equity rotations, with small caps gaining from anticipated rate stability post-2025 cuts and fiscal policies like tax incentives boosting domestic revenues. Quality factors shine in uncertainty, favoring stable earners amid geopolitical tensions and AI-driven tech concentration. Small caps (Russell 2000) benefit from lower rates easing debt burdens (higher floating-rate exposure), M&A upticks, and sector breadth (Financials, Industrials leading). Risks include persistent inflation delaying cuts, election volatility, and small-cap sensitivity to recessions. Capital flows favor diversification beyond mega-caps, with quality providing downside buffers versus cyclical small-cap beta.

Performance and Positioning Comparison

In recent market cycles, URTY's 3x small-cap leverage has amplified gains during rotations, outperforming in early 2026 amid small-cap surges (~12% YTD for Russell 2000 unlevered), driven by value sectors and rate clarity. QULL's 2x quality exposure has shown steadier advances, benefiting from resilient large/mid-caps in tech-heavy quality (e.g., NVDA, MSFT) amid volatility. Over recent months, small caps rotated ahead on earnings acceleration and domestic focus, but quality's lower beta (~1.93 vs. URTY's amplified volatility) aids risk-adjusted positioning. URTY excels in bull phases; QULL in choppy trends tied to macro shifts like yield curve steepening.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to uncover ETF comparisons like QULL and URTY.

Tickeron AI Verdict

Tickeron’s AI currently favors QULL for its structural advantages in cost efficiency, sector-neutral diversification across quality large/mid-caps, and lower leverage (2x quarterly vs. 3x daily), reducing decay in sideways markets. Amid small-cap momentum, URTY offers higher upside potential, but QULL's focus on proven earners aligns better with trend consistency and moderated risk exposure (~60% probability of relative outperformance over multi-month horizons).

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

VS
QULL vs. URTY commentary
Jun 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QULL is a Hold and URTY is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
URTY has more net assets: 335M vs. QULL (40.9M). URTY has a higher annual dividend yield than QULL: URTY (36.933) vs QULL (12.653). QULL was incepted earlier than URTY: QULL (5 years) vs URTY (16 years).
QULLURTYQULL / URTY
Gain YTD12.65336.93334%
Net Assets40.9M335M12%
Total Expense RatioN/A0.95-
TurnoverN/A91.00-
Yield0.000.62-
Fund Existence5 years16 years-
TECHNICAL ANALYSIS
Technical Analysis
QULLURTY
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
86%
Bullish Trend 3 days ago
90%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
QULL
Daily Signal:
Gain/Loss:
URTY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PGEN3.880.17
+4.72%
Precigen
KYMR78.211.30
+1.69%
Kymera Therapeutics
RADX4.310.06
+1.41%
Radiopharm Theranostics Limited
UCFI5.51N/A
N/A
CN Healthy Food Tech Group Corp.
AMGN337.73-6.83
-1.98%
Amgen

URTY and

Correlation & Price change

A.I.dvisor tells us that URTY and SMCI have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that URTY and SMCI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URTY
1D Price
Change %
URTY100%
-3.13%
SMCI - URTY
31%
Poorly correlated
-27.98%